MYGN
Myriad Genetics Inc. (MYGN)
NASDAQ · Healthcare
Myriad Genetics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Myriad Genetics Inc. revenue for the quarter ending March 31, 2026 was 200.4 M, a 2.30% increase year-over-year.
- Myriad Genetics Inc. revenue for the twelve months ending March 31, 2026 was 815.1 M, a 0.46% decrease year-over-year.
- Myriad Genetics Inc. annual revenue for 2025 was 824.5 M, a 1.56% decrease from 2024.
- Myriad Genetics Inc. annual revenue for 2024 was 837.6 M, a 11.21% increase from 2023.
- Myriad Genetics Inc. annual revenue for 2023 was 753.2 M, a 11.03% increase from 2022.
- Myriad Genetics Inc. annual revenue for 2022 was 678.4 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Myriad Genetics Inc. Earnings — FAQ
Myriad Genetics Inc. (MYGN) earnings over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MYGN's earnings history?
The chart and table above show Myriad Genetics Inc.'s earnings by year and by quarter, including the growth rate.